Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Healthcare Industry Digest.
Press releases published on June 20, 2025
Xerosis Treatment Market Report 2025 – Strategic Insights For Companies Seeking Expansion, Growth, Competitive Advantage
EIN Presswire
·
June 20, 2025
The Business Research Company’s Xerosis Treatment Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 20, 2025 /EINPresswire.com/ -- What Does The Growth Trajectory Of The Xerosis …
AI in Genomics Market Size Expected to Reach $9,859.7 Million by 2031 | Freenome holdings, Thermo fisher scientific
EIN Presswire
·
June 20, 2025
PORTLAND, IL, UNITED STATES, June 20, 2025 /EINPresswire.com/ -- According to a new report published by Allied Market Research, titled, “AI in Genomics Market” was valued at $346.3 million in 2021, and is projected to reach $9,859.7 million by 2031, …
Inozyme Pharma, Inc. Announces Postponement of 2025 Annual Meeting of Stockholders
GlobeNewswire
·
June 20, 2025
BOSTON, June 20, 2025 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY) today announced that it has postponed its 2025 Annual Meeting of Stockholders (the “Annual Meeting”), which was scheduled to be held on June 25, 2025, in light of the previously …
Brachytherapy Market Face Uncertainty as Economic Indicators Signal Mixed Outlook
EIN Presswire
·
June 20, 2025
PORTLAND, IL, UNITED STATES, June 20, 2025 /EINPresswire.com/ -- According to the report published by Allied Market Research, the global brachytherapy market garnered $0.83 billion in 2021, and is estimated to generate $1.6 billion by 2031, manifesting a …
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
June 20, 2025
NOVATO, Calif., June 20, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultra-rare diseases, today reported the grant of …
Cyclacel Pharmaceuticals Announces $3 Million Private Placement Offering of Convertible Preferred Stock
GlobeNewswire
·
June 20, 2025
KUALA LUMPUR, June 20, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (“Cyclacel”) (NASDAQ: CYCC, NASDAQ: CYCCP), a biopharmaceutical company that develops innovative cancer medicine, today announced that it has entered into a securities purchase …
The Ensign Group, Inc. Announces Retirement of Its Executive Chairman
GlobeNewswire
·
June 20, 2025
SAN JUAN CAPISTRANO, Calif., June 20, 2025 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG or “Ensign”), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living services, physical, …
AIM ImmunoTech Announces NYSE American Notice of Noncompliance With Minimum Stockholders’ Equity Requirements
GlobeNewswire
·
June 20, 2025
NYSE American previously issued similar warning for same matter and issued the new notice because the deficiency remains as of March 31, 2025 AIM has until June 11, 2026 to regain compliance OCALA, Fla., June 20, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc …
Zenas BioPharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
June 20, 2025
WALTHAM, Mass., June 20, 2025 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of therapies for …
Heat Therapy Market Market Is Booming So Rapidly with 5.7% CAGR from 2022 to 2031
EIN Presswire
·
June 20, 2025
PORTLAND, IA, UNITED STATES, June 20, 2025 /EINPresswire.com/ -- According to the report published by Allied Market Research, the global heat therapy market garnered $1.4 billion in 2021, and is estimated to generate $2.4 billion by 2031, manifesting a …
ArriVent Announces Investor Event on Firmonertinib Path Forward for EGFR PACC Mutant NSCLC
GlobeNewswire
·
June 20, 2025
NEWTOWN SQUARE, Pa., June 20, 2025 (GLOBE NEWSWIRE) -- ArriVent BioPharma, Inc. (Company or ArriVent) (Nasdaq: AVBP), a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical therapeutics, today announced …
Larimar Therapeutics Announces Regulatory Update Call on the Nomlabofusp Program for the Treatment of Friedreich’s Ataxia
GlobeNewswire
·
June 20, 2025
BALA CYNWYD, Pa., June 20, 2025 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (Larimar) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced that the Company will host a …
Wave Life Sciences Announces Oral Presentation of Preclinical Data Supporting WVE-007’s Mechanism (INHBE) to Reduce Fat, Preserve Muscle, and Induce Healthy Weight Loss at ADA's Annual Scientific Sessions
GlobeNewswire
·
June 20, 2025
Presentation to highlight WVE-007 (INHBE GalNAc-siRNA) as a potential novel and unique obesity treatment leading to healthy weight loss and supporting preclinical data demonstrating potent and durable reduction in Activin E resulting in fat loss with …
PharmAla Files Preliminary Base Shelf Prospectus
GlobeNewswire
·
June 20, 2025
TORONTO, June 20, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class molecules (including its …
Shuttle Pharmaceuticals Announces Pricing of $4.25 Million Private Placement Priced At-the-Market
GlobeNewswire
·
June 20, 2025
GAITHERSBURG, Md., June 20, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer …
Lipella Pharmaceuticals Announces Delisting from Nasdaq Capital Market
GlobeNewswire
·
June 20, 2025
PITTSBURGH, June 20, 2025 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (OTC: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on developing therapies for diseases with significant unmet needs, today announced that the …
Nicotine Replacement Therapy Market on Steady Rise: Projected to Reach $5.9 Billion by 2031
EIN Presswire
·
June 20, 2025
PORTLAND, OR, UNITED STATES, June 20, 2025 /EINPresswire.com/ -- The global nicotine replacement therapy (NRT) market is witnessing significant growth, driven by rising health awareness, regulatory support, and technological advancements. Valued at $2.7 …
SlimJaro Advanced Weight Loss Supplement in 2025: Can Targeting Inflammation Extra Body Fat, Read Slim Jaro Benefits & Side Effects
GlobeNewswire
·
June 20, 2025
New York City, NY, June 20, 2025 (GLOBE NEWSWIRE) -- In 2025, weight loss has become more complicated than simply cutting calories or hitting the gym. Many people around the world are following standard health advice yet still struggle with slow or …
Marquis Who's Who Honors Pamela M. Cipriano, DNP, for Expertise in Health Care
EIN Presswire
·
June 20, 2025
Dr. Cipriano, a distinguished figure in the medical community, has dedicated over three decades to advancing health care practices and patient outcomes. THOMASTON, CT, UNITED STATES, June 20, 2025 /EINPresswire.com/ -- Pamela M. Cipriano, DNP, has been …
OSE Immunotherapeutics Reaffirms Commitment to Holding a Transparent and Serene General Meeting in Compliance with Market Rules
GlobeNewswire
·
June 20, 2025
OSE Immunotherapeutics Reaffirms Commitment to Holding a Transparent and Serene General Meeting in Compliance with Market Rules Nantes, June 20th, 2025, 7:30 p.m. - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), publishes a “Questions and …